Edward T Mathers Reneo Pharmaceuticals, Inc. (RPHM) insider trading activity

RPHM Quotes by TradingView

Edward T Mathers is of Reneo Pharmaceuticals, Inc.. Currently has a direct ownership of 2,580 shares of RPHM, which is worth approximately $4,334. The most recent transaction as insider was on Mar 31, 2025, when has been sold 2,580 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.58K
n/a 3M change
n/a 12M change
Total Value Held $4,334

Edward T Mathers Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 31 2025
BUY
Grant, award, or other acquisition
-
2,580 Added 50.0%
2,580 Class A Common Stock

Also insider at

MIRM
Mirum Pharmaceuticals, Inc. Healthcare
Director
RYTM
RHYTHM PHARMACEUTICALS, INC. Healthcare
SYBX
SYNLOGIC, INC. Healthcare
Director
TRVI
Trevi Therapeutics, Inc. Healthcare
INZY
Inozyme Pharma, Inc. Healthcare
AKUS
Akouos, Inc. Healthcare
Director
GLUE
Monte Rosa Therapeutics, Inc. Healthcare
> 10% Shareholder
SNTI
Senti Biosciences, Inc. Healthcare
BHG
Bright Health Group Inc. Healthcare
SVRA
Savara Inc Healthcare
> 10% Shareholder
FREQ
Frequency Therapeutics, Inc. Healthcare
MBX
MBX Biosciences, Inc.
ETM

Edward T Mathers

Timonium, MD

Track Institutional and Insider Activities on RPHM

Follow Reneo Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPHM shares.

Notify only if

Insider Trading

Get notified when an Reneo Pharmaceuticals, Inc. insider buys or sells RPHM shares.

Notify only if

News

Receive news related to Reneo Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RPHM